The Latest Headlines at Stock Observer
What Coupang (CPNG) Said on Its Q3 Earnings Call
Coupang (NYSE:CPNG) reported third-quarter 2026 revenue growth that exceeded its prior outlook in constant-currency terms, while management said its Product Commerce business remains on track to recover margins to approximately pre-incident... More of this article »
What Janus Living (JAN) Said on Its Q3 Earnings Call
Janus Living (NYSE:JAN) raised its 2026 outlook after reporting third-quarter gains in revenue, profitability and same-store operating performance, while continuing to expand its senior housing portfolio through acquisitions. President... More of this article »
Critical Analysis: Rallybio (NASDAQ:RLYB) and CRISPR Therapeutics (NASDAQ:CRSP)
Rallybio (NASDAQ:RLYB – Get Free Report) and CRISPR Therapeutics (NASDAQ:CRSP – Get Free Report) are both healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of... More of this article »
Critical Contrast: Ames National (NASDAQ:ATLO) versus Shinhan Financial Group (NYSE:SHG)
Shinhan Financial Group (NYSE:SHG – Get Free Report) and Ames National (NASDAQ:ATLO – Get Free Report) are both finance companies, but which is the better stock? We will contrast the two businesses based on the strength... More of this article »
Head to Head Survey: AMN Healthcare Services (NYSE:AMN) & Brookdale Senior Living (NYSE:BKD)
AMN Healthcare Services (NYSE:AMN – Get Free Report) and Brookdale Senior Living (NYSE:BKD – Get Free Report) are both healthcare companies, but which is the better stock? We will contrast the two businesses based on the... More of this article »-logo-1200x675.png){kind=logo}
Comparing Skandinaviska (SVKEF) and Its Rivals
Skandinaviska (OTCMKTS:SVKEF – Get Free Report) is one of 920 public companies in the “Banks” industry, but how does it compare to its rivals? We will compare Skandinaviska to similar companies based on the strength... More of this article »
Financial Survey: Daily Journal Corp. (S.C.) (DJCO) and Its Peers
Daily Journal Corp. (S.C.) (NASDAQ:DJCO – Get Free Report) is one of 953 public companies in the “Software” industry, but how does it compare to its competitors? We will compare Daily Journal Corp. (S.C.) to similar... More of this article »
comScore Q3 Earnings Call Highlights
comScore (NASDAQ:SCOR) reported third-quarter revenue of $76.2 million, down 14.3% from the prior-year period, as the media measurement company continued executing a restructuring and transformation program intended to lower costs,... More of this article »
Analyzing Bristol Myers Squibb (NYSE:BMY) and Bausch Health Cos (NYSE:BHC)
Bausch Health Cos (NYSE:BHC – Get Free Report) and Bristol Myers Squibb (NYSE:BMY – Get Free Report) are both healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength... More of this article »
Tarsus Pharmaceuticals Q3 Earnings Call Highlights
Tarsus Pharmaceuticals (NASDAQ:TARS) reported record third-quarter sales for XDEMVY and raised its full-year revenue outlook, citing increased patient demand, deeper prescribing activity among eye care professionals and a growing... More of this article »
Navigator’s profit more than doubles on vessel sales, but adjusted EBITDA slips (NYSE: NVGS)
What happened Navigator Holdings Ltd. (NYSE: NVGS) earned $78.3 million in third-quarter net income attributable to stockholders, mainly from profit on vessel sales. A year earlier it earned $33.2 million. Adjusted EBITDA, which leaves... More of this article »
PTC Therapeutics (NASDAQ:PTCT) to Buy Back $500 million in Outstanding Stock
PTC Therapeutics (NASDAQ:PTCT – Get Free Report) declared that its board has authorized a share buyback program on Tuesday, November 3rd, RTT News reports. The company plans to buy back $500 million in shares. This repurchase... More of this article »
Mirum Pharmaceuticals Q3 Earnings Call Highlights
Mirum Pharmaceuticals (NASDAQ:MIRM) reported third-quarter net product sales of $186 million and raised its full-year 2026 net product sales guidance to $715 million to $720 million, citing continued growth of LIVMARLI and its bile... More of this article »